Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christine Haakenson"'
Autor:
Moshe Talpaz, Dan R. Robinson, Tim Tesmer, Todd M. Morgan, Robert J. Lonigro, David Smith, Yugang Wang, Chia Jen Liu, John P. Langmore, John C. Krauss, Missy Tuck, Maha Hussain, Scott Brockman, Scott A. Tomlins, Qing Kang, Ajjai Alva, Arul M. Chinnaiyan, Emmanuel Kamberov, Rashmi Chugh, Michael J. Quist, Kirk Herman, Muneesh Tewari, Nithya Ramnath, Christine Haakenson, Felix Y. Feng, Amy Gursky, Daniel H. Hovelson, Ryan E. Mills, Malathi Kandarpa, James Henderson, Catherine S. Grasso, Hatim Husain
Publikováno v:
Oncotarget
Oncotarget, vol 8, iss 52
Oncotarget, vol 8, iss 52
Current cell-free DNA (cfDNA) next generation sequencing (NGS) precision oncology workflows are typically limited to targeted and/or disease-specific applications. In advanced cancer, disease burden and cfDNA tumor content are often elevated, yieldin
Autor:
Kirk Herman, Nithya Ramnath, Rashmi Chugh, Chia Jen Liu, Missy Tuck, Moshe Talpaz, Daniel H. Hovelson, Christine Haakenson, Yugang Wang, Hatim Husain, Scott A. Tomlins, Todd M. Morgan, Ryan E. Mills, John P. Langmore, Muneesh Tewari, Qing Kang, Emmanuel Kamberov, Arul M. Chinnaiyan, David C. Hyland, John C. Krauss
Publikováno v:
Journal of Clinical Oncology. 35:144-144
144 Background: Although cell free DNA (cfDNA) profiling by next generation sequencing (NGS) holds great promise for precision oncology, the inability to estimate tumor content a priori typically results in ultra-deep sequencing (e.g. 10,000x) based